Watch Presentation:
Decoding Biotech Market Access A Critical Driver of Biotech Value

Decoding Biotech Market Access A Critical Driver of Biotech Value

In today’s rapidly evolving life sciences landscape, market access has become one of the most critical—and often misunderstood—drivers of biotech success. Decoding Market Access: A Critical Driver of Biotech Value is a focused webinar designed for biotech investors, analysts, and the biotech leadership teams seeking their capital, offering a clear view into how reimbursement dynamics, payer expectations, and real-world value considerations shape the commercial trajectory—and long-term value—of emerging therapies.

During this session, our panel briefly recaps the recent market access takeaways from JPM 2026 and discuss the following:

• The core components of market access, from early-stage evidence planning and health-economic strategy to pricing, reimbursement pathways, and post-launch performance.
• Key questions investors should ask during due diligence, the market signals that can predict access challenges, and the critical role that payer engagement plays in determining whether innovative treatments reach patients—and achieve meaningful returns.
• The importance of understanding how aspects of the US policy and payer environment play into product development, pricing, and launch.
• Examples of how successful biotechs have leveraged market access to drive investor confidence.

Whether you are evaluating a biotech opportunity or preparing your company for the next phase of financing or commercialization, this webinar provides a shared lens into how market access shapes both investment risk and commercial success.